IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine.
As India’s pharmaceutical sector shifts from volume-driven growth to global-grade quality and compliance, Arpit Bhatia, Director, Laborate Pharmaceuticals, discusses evolving manufacturing standards, regulator...
As pharmaceutical manufacturing evolves into a technology-driven and globally integrated sector, academic institutions must align closely with industry expectations to build future-ready talent, said Dr. Supriya Shi...
On the eve of Women’s Day, Shivani Wagh, Joint MD, Supriya Lifescience, speaks to Pharma Industrial India about leadership, global expansion, building inclusive teams, and advancing opportunities for women in ...
Why must personnel apparel be taken seriously? Using Personal Protective Equipment (PPE) is one of the most important contamination control decisions in pharmaceutical manufacturing....
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success....
Falgun Jani, Business Head – India, Freudenberg Medical, explores the growing role of Single-use Systems (SUS) in enabling sustainable pharmaceutical manufacturing, highlighting their economic advantages, oper...
By Darshana Daga
By Pharma Industrial India
Latest news in...
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy